DPHARM Idol Disrupt 2026

Session details:

Now in its 15th year, DPHARM Idol Disrupt features a select group of innovators who present what they believe to be a disruptive service or technology that could be a changing force for clinical trials. Each of the pre-approved presenting companies give a quick-fire session followed by questions from the DPHARM distinguished judging panel. The judges deliberate following the session and announce the winner the following morning. DPHARM Idol will kick off with the 2025 winner.

DPHARM Idol 2026 Winner Where They Are a Year Later
Maya Zlatanova, CEO, TrialHub

DPHARM Idol Disrupt 2026 Finalists

DPHARM Idol Disrupt Judges

Tiffany Bratts, Ed.D, MPH, MS, Director, Clinical Patient Engagement and Inclusion, Gilead
Elspeth Carnan, PhD, VP, Trial Delivery Support, BMS
Martina DiMeglio, Clinical Research Lead, Clinical Trials Office, Sidney Kimmel Comprehensive Cancer Center at Jefferson Health
Joe Dustin, Sr Director, Digital Clinical Development, Sanofi 
Esther Dyson, Author, “In Defense of Limits: Human Time and AI Scale (2027)
Yusuf Ghadiali, Executive Director, Global Clinical Operations & Planning, Daiichi Sankyo
Hassan Kadhim, Executive Director, Clinical Operations Process and Performance Excellence, Summit Therapeutics
Sabina Kineen, Patient Advocate, Lived-experience Expert, Fabry Support & Information Group
Doug Schantz, SVP, Clinical Operations, AskBio
Anthony K. Taylor, DHSc, MSPharm, PMP, Director, Clinical Site and Patient Insights, AbbVie
Donna Usiskin, Chief Strategy Officer, New Enterprise Ventures